JC: Peri-intubation cardiovascular collapse in critically ill patients.
Given the high rate of peri-intubation collapse seen here, consider alternatives to propofol for RSI when possible, but remember that this association is purely observational. Do not change your standard RSI armamentarium solely based on this data; instead, use it as a prompt to review your local protocols and perhaps optimize adjuncts or timing around induction agents.
This piece highlights the concerning prevalence of peri-intubation cardiovascular collapse, which was observed in over 40% of critically ill patients within the INTUBE cohort. The analysis pointed toward propofol as a modifiable factor independently associated with this hemodynamic instability, and further noted that its use correlated with increased risks of both ICU admission and 28-day mortality. While these findings are intriguing for optimizing rapid sequence intubation (RSI) protocols, it is crucial to remember that the evidence presented remains observational in nature. Therefore, while propofol warrants consideration during RSI planning, clinicians should approach any changes based on this data with caution due to the lack of causal proof.